No

Antihypertensive Agent, Combination

Treatment of hypertension, however, not indicated for initial treatment of hypertension; replacement therapy in patients receiving separate dosage forms (for patient convenience); when monotherapy with one component fails to achieve desired antihypertensive effect, or when dose-limiting adverse effects limit upward titration of monotherapy

C/D (2nd and 3rd trimesters)

Adults: Oral: One tablet daily, if further blood pressure control is required, increase dosage to two tablets daily

Combination therapy for the treatment of hypertension should be individualized for each patient. Potential advantages for enalapril and diltiazem combination therapy may include improved compliance and synergistic reductions in blood pressure with an accompanied reduction in side effects.

No information available to require special precautions

Calcium channel blockers cause gingival hyperplasia in approximately 1% of patients. There have been fewer reports with felodipine than with other CCBs. The hyperplasia will disappear with cessation of drug therapy. Consultation with physician is suggested.

See individual agents. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Consult prescriber if breast-feeding.

Tablet, extended release: Enalapril maleate 5 mg and diltiazem maleate 180 mg